Narrative reviewcited by the Tayebat archiveabstract only checked A-UPF-23 standard review

Trans fats and heart disease (review)

Trans fatty acids and cardiovascular disease.

Overview

Mozaffarian D et al.. N Engl J Med 2006 · PMID 16611951 · DOI 10.1056/NEJMra054035

A review of trans fats and heart disease; no abstract was available to assess.

Does the study support the specific claim? Unclear · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Effects of trans fatty acids on CVD.

How was the study done?

Narrative review.

How many people, animals or samples were studied?

Not applicable; Not applicable

What was actually found?

No abstract available in PubMed; content not reviewed.

How large was the observed effect?

Not applicable

What do the results mean in everyday life?

Not assessable.

What are the study's limitations?

Content not reviewed (no abstract)

What does it say about Elawady's specific claim?

Indirect context for C-UPF-03 (industrial trans fats are one historical UPF component).

Do the results apply to Germany and Europe?

Moderate.

What can explicitly not be concluded from this study?

Anything specific without full text.

Scientific in-depth review

1. Full reference

Authors
Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC
Journal
N Engl J Med
Year
2006
Identifier
PMID 16611951 DOI 10.1056/NEJMra054035
Verification
verified – PubMed E-utilities efetch, 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

No COI statement; NHLBI

2. Research question

Effects of trans fatty acids on CVD.

3. Study design and population

Study design
Narrative review – Narrative review.
Population

Not applicable

Country

USA (authors)

Period

2006

Sample size

Not applicable

Inclusion and exclusion criteria

Not applicable

4. Methods and endpoints

Exposure / intervention

Trans fatty acids

Comparator

Not applicable

Endpoints

CVD

Statistical methods

Not applicable

5. Actual results

Results

No abstract available in PubMed; content not reviewed.

Absolute risks

not applicable

Authors' conclusion

Not available (no abstract).

6. Strengths

  • Authoritative review

7. Weaknesses

  • Content not reviewed (no abstract)

8. Risk of bias

Orienting tool
none applicable
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
not assessable
Rationale

Not applicable.

9. Assessment of the statistical interpretation

Not applicable.

10. Relevance to the specific claim

Indirect context for C-UPF-03 (industrial trans fats are one historical UPF component).

11. Independent contrary findings

None reviewed.

12. Transferability to Germany and Europe

Moderate.

13. Overall methodological judgement

Not assessable at abstract level.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biasnot assessable
Precision of resultsnot applicable
Directnessindirect
Reproducibilityunknown
Consistency with the overall evidenceunknown
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not verifiable

14. Open questions

Not applicable.

15. Linked fact checks

Use by the Tayebat archive

Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.

What the archive says about the study

Listed in the archive bibliography only (no archive interpretation card).

A. What was actually studied?

Trans fats and CVD.

B. What did the authors find?

Not reviewed (no abstract).

C. What conclusions do the authors themselves draw?

Not reviewed.

D. What does the archive derive from it?

Implicitly: industrial fats in UPF are harmful.

E. Is this derivation scientifically justified?

Cannot be assessed from the abstract; not specific to UPF.

Adequacy of the interpretation (by the archive)
not verifiable